(Q37992796)

26 August 2017

language of work or name

English

0 references

publication date

13 March 2012

1 reference

Nature Reviews Nephrology

26 August 2017

published in

1 reference

26 August 2017

volume

8

1 reference

26 August 2017

issue

6

1 reference

26 August 2017

page(s)

362-369

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneph.2012.41

26 August 2017

exact match

0 references

cites work

Cardiovascular and noncardiovascular mortality among patients starting dialysis

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Progress and challenges in translating the biology of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Atherosclerosis: current pathogenesis and therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Monocytes in atherosclerosis: subsets and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Inflammation, atherosclerosis, and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

The immune response in atherosclerosis: a double-edged sword

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Fractalkine preferentially mediates arrest and migration of CD16+ monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Blood monocytes consist of two principal subsets with distinct migratory properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Nomenclature of monocytes and dendritic cells in blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Monocyte subpopulations and their differentiation patterns during infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Common CCR5-del32 frameshift mutation associated with serum levels of inflammatory markers and cardiovascular disease risk in the Bruneck population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

CCR5 deletion protects against inflammation-associated mortality in dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Monocytes of patients with familial hypercholesterolemia show alterations in cholesterol metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Different capacity of monocyte subsets to phagocytose iron-oxide nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

CD14dimCD16+ and CD14+CD16+ monocytes in obesity and during weight loss: relationships with fat mass and subclinical atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Association of monocyte subsets with vulnerability characteristics of coronary plaques as assessed by 64-slice multidetector computed tomography in patients with stable angina pectoris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Association of monocyte subset counts with coronary fibrous cap thickness in patients with unstable angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Human monocyte heterogeneity--a nephrological perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Selective blockade of the antigen-receptor-mediated pathway of T cell activation in patients with impaired primary immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Aspects of immune dysfunction in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Immunologic function and survival in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

T cell activation defect in hemodialysis patients: evidence for a role of the B7/CD28 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

High extracellular inorganic phosphate concentration inhibits RANK-RANKL signaling in osteoclast-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

On-line hemodiafiltration reduces the proinflammatory CD14+CD16+ monocyte-derived dendritic cells: A prospective, crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

CD14++CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Haemodialysis monocytopenia: differential sequestration kinetics of CD14+CD16+ and CD14++ blood monocyte subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Toll-like receptor expression in monocytes in patients with chronic kidney disease and haemodialysis: relation with inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Circulating monocyte subpopulations with high expression of angiotensin-converting enzyme predict mortality in patients with end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Haemodialysis-induced transient CD16+ monocytopenia and cardiovascular outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Monocyte angiotensin converting enzyme expression may be associated with atherosclerosis rather than arteriosclerosis in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Different functions of monocyte subsets in familial hypercholesterolemia: potential function of CD14+ CD16+ monocytes in detoxification of oxidized LDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6C hi and Ly6C lo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Dissecting Inflammation in ESRD: Do Cytokines and C-Reactive Protein Have a Complementary Prognostic Value for Mortality in Dialysis Patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Associations between differential leucocyte count and incident coronary heart disease: 1764 incident cases from seven prospective studies of 30,374 individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Definition of human blood monocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Standardized single-platform assay for human monocyte subpopulations: Lower CD14+CD16++ monocytes in females

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

A Clonogenic Bone Marrow Progenitor Specific for Macrophages and Dendritic Cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Polymorphisms in the CC-chemokine receptor-2 (CCR2) and -5 (CCR5) genes and risk of coronary heart disease among US women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Selective mobilization of CD14(+)CD16(+) monocytes by exercise

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

CD16+ monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Circulating monocyte subsets and cardio - vascular risk factors in coronary artery disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Monocyte heterogeneity in obesity and subclinical atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Association between circulating monocyte subsets and in-stent restenosis after coronary stent implantation in patients with ST-elevation myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Production of interleukin-6, tumor necrosis factor alpha and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Strong depletion of CD14(+)CD16(+) monocytes during haemodialysis treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Stress-induced premature senescence in mononuclear cells from patients on long-term hemodialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Difference in the blood monocyte phenotype between uremic patients and healthy controls: its relation to monocyte differentiation into macrophages in the peritoneal cavity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Expression of Fc gamma receptor III (CD16) on monocytes during hemodialysis in patients with chronic renal failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Increased expression of monocytic angiotensin-converting enzyme in dialysis patients with cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.41

Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice.

31 March 2020

1 reference

12 December 2020

Production of proinflammatory and regulatory monokines in hemodialysis patients shown at a single-cell level

1 reference

12 December 2020

Identification and characterization of a novel monocyte subpopulation in human peripheral blood.

1 reference

12 December 2020

Expanded CD14+ CD16+ monocyte subpopulation in patients with acute and chronic infections undergoing hemodialysis.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2012.41

1 reference

release_axx64anv7jbeboqexevi2e2lj4

26 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/axx64anv7jbeboqexevi2e2lj4

24 November 2022

mapped directly with Wikidata item

1 reference